Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NCT05690048 - Atezolizumab + Bevacizumab + Vancomycin vs Atezolizumab + Bevacizumab + Fecal microbiota transplantation (FMT) + Vancomycin & Hepatocellular Carcinoma (HCC) is a randomized clinical phase II treatment trial studying Atezolizumab + Bevacizumab + Vancomycin or Atezolizumab + Bevacizumab + Fecal microbiota transplantation (FMT) + Vancomycin in patients with Hepatocellular Carcinoma (HCC)
Assessment of immunogenicity (Tumoral CD8+ T cell infiltration), safety
No published results could be found as of February 202…